Active Ingredient History
Pittsburgh compound B (PiB) is a radioactive analog of thioflavin T, which can be used in positron emission tomography scans to image beta-amyloid plaques in neuronal tissue. Due to this property, Pittsburgh compound B may be used in investigational studies of Alzheimer's disease. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alcoholism (Early Phase 1)
Alzheimer Disease (Phase 4)
Aphasia (Phase 1)
Aphasia, Primary Progressive (Phase 1)
Atherosclerosis (Phase 2)
Atrophy (Phase 1)
Breast Neoplasms (Phase 1)
Cerebral Amyloid Angiopathy (Phase 3)
Cerebral Hemorrhage (Phase 3)
Cognition Disorders (Phase 3)
Cognitive Dysfunction (Phase 2)
Dementia (Phase 1)
Dementia, Vascular (Phase 4)
Frontotemporal Dementia (Phase 4)
Intracranial Hemorrhages (Phase 3)
Lewy Body Disease (Phase 4)
Ovarian Neoplasms (Phase 1)
Parkinson Disease (Phase 2)
Primary Progressive Nonfluent Aphasia (Phase 1)
Speech Disorders (Phase 1)
Vascular Diseases (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue